Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass

Thoracic and Cardiovascular Surgeon

Volumn 55, Issue 1, 2007, Pages 24-31

  Börgermann, Jochen ^a,b   Friedrich, I ^a   Scheubel, R ^a   Kuss, O ^a   Lendemans, S ^b   Silber, R E ^a   Kreuzfelder, E ^b   Flohe S ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cardiopulmonary bypass; Granulocyte macrophage colony stimulating factor; HLA DR expression; Immune dysfunction; Immunomodulation; Monocytes

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; BIOLOGICAL MARKER; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; HEART SURGERY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOGENESIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HEART DISEASE; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MONOCYTE; PHYSIOLOGY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART DISEASES; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 34047166494     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924621     Document Type: Article

References (30)

1. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252
2. Naldini A, Borrelli E, Cesari S et al. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass. Cytokine 1995; 7: 165-170
3. Kleinschmidt S, Wanner GA, Bussmann D et al. Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline. Shock 1998; 9: 12-20
4. Börgermann J, Friedrich I, Flohé S et al. Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities. J Thorac Cardiovasc Surg 2002; 124: 608-617
5. Hiesmayr MJ, Spittler A, Lassnigg A et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 1999; 115: 315-323
6. Rinder CS, Mathew JP, Rinder HM et al. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med 1997; 129: 592-602
7. van der Poll T, Jansen J, Endert E et al. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994; 62: 2046-2050
8. van der Poll T, Coyle SM, Barbosa K et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-719
9. Munoz C, Carlet J, Fitting C et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-1754
10. Majetschak M, Flach R, Kreuzfelder E et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 1999; 27: 313-318
11. Ditschkowski M, Kreuzfelder E, Rebmann V et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229: 246-254
12. Hershman MJ, Cheadle WG, Wellhausen SR et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77: 204-207
13. Flohé S, Lendemans S, Selbach C et al. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003; 31: 2462-2469
14. Hayes MP, Freeman SL, Donnelly RP. IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine 1995; 7: 427-435
15. Randow F, Docke WD, Bundschuh DS et al. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol 1997; 158: 2911-2918
16. Docke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678-681
17. Flohé S, Borgermann J, Lim L et al. Interferon-gamma counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass. J Endotoxin Res 2000; 6: 431-436
18. Flohé S, Borgermann J, Dominguez FE et al. Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis. Shock 1999; 12: 17-24
19. Kawasaki T, Ogata M, Kawasaki C et al. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 2001; 92: 1322-1326
20. Ditschkowski M, Kreuzfelder E, Majetschak M et al. Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury. Eur J Surg 1999; 165: 1129-1133
21. Allen ML, Peters MJ, Goldman A et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002; 30: 1140-1145
22. Strohmeyer JC, Blume C, Meisel C et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry 2003; 53 B: 54-62
23. Hornell TM, Beresford GW, Bushey A et al. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. J Immunol 2003; 171: 2374-2383
24. Lee KY, Suh BG, Kim JW et al. Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes. Exp Mol Med 2000; 32: 210-215
25. Nierhaus A, Montag B, Timmler N et al. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 2003; 29: 646-651
26. Bilgin K, Yaramis A, Haspolat K et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107: 36-41
27. Meropol NJ, Wood DE, Nemunaitis J et al. Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group. J Clin Oncol 1998; 16: 1167-1173
28. Presneill JJ, Harris T, Stewart AG et al. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002; 166: 138-143
29. Wu FP, Westphal JR. Hoekman K et al. The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma. Cytokine 2004; 25: 68-72
30. Cottier-Fox MH, Lapidot T, Petit I et al. Stem cell mobilization. Hematology (Am Soc Hematol Educ Program) 2003: 419-437